Search Videos and More


Online Testing Tool Identifies People Likely to Benefit from Genetic Testing for Inherited Risk for Certain Cancers News

Online Testing Tool Identifies People Likely to Benefit from Genetic Testing for Inherited Risk for Certain Cancers

An online tool developed by researchers and physicians at Dana-Farber Cancer Institute can accurately and rapidly identify people who should undergo testing for inherited genetic changes that raise the risk of developing certain cancers, a new study shows.
Young-Onset Colorectal Cancer Center Gut Instincts Series: Best Practices for Symptom Management Video

Young-Onset Colorectal Cancer Center Gut Instincts Series: Best Practices for Symptom Management

Dana-Farber’s Young-Onset Colorectal Cancer Center's Gut Instincts series continued on Tuesday, January 25 with an educational workshop on Best Practices for Symptom Management.
Young-Onset Colorectal Cancer Center Annual Forum Research Keynote Video

Young-Onset Colorectal Cancer Center Annual Forum Research Keynote

At the Young-Onset Colorectal Cancer Center's third annual Patient and Family Forum, a Research Keynote lead by Jonathan Nowak, MD, PhD and Benjamin Schlechter, MD, discussed immunotherapy and CAR-T cell therapy in young-onset colorectal cancer.
Dana-Farber Researchers Present Findings at 2022 ASCO Genitourinary Cancers Symposium News

Dana-Farber Researchers Present Findings at 2022 ASCO Genitourinary Cancers Symposium

Dana-Farber Cancer Institute researchers presented important research studies during the 2022 ASCO Genitourinary (GU) Cancers Symposium, that took place from February 17-19, both virtually and in-person in San Francisco.
A Case of Mistaken Identity: Researchers Unmask Cellular Source of Barrett’s Esophagus News

A Case of Mistaken Identity: Researchers Unmask Cellular Source of Barrett’s Esophagus

Two recent studies by Dana-Farber Cancer Institute scientists correct a longstanding misconception about the origins of Barrett’s esophagus, and in doing so may point to new avenues of treatment or prevention to lower the risk of esophageal cancer.
Survival Similar for Younger and Older Patients with Metastatic Colorectal Cancer, Study Finds News

Survival Similar for Younger and Older Patients with Metastatic Colorectal Cancer, Study Finds

Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.
New Research Initiative Launches for All Patients Ever Diagnosed with Colorectal Cancer News

New Research Initiative Launches for All Patients Ever Diagnosed with Colorectal Cancer

Count Me In, a nonprofit cancer research initiative, is inviting all patients across the United States and Canada who have ever been diagnosed with colorectal cancer to participate in research and help drive new discoveries related to this disease.
Vitamin D May Protect Against Young-Onset Colorectal Cancer News

Vitamin D May Protect Against Young-Onset Colorectal Cancer

Consuming higher amounts of Vitamin D – mainly from dietary sources – may help protect against developing young-onset colorectal cancer or precancerous colon polyps, according to the first study to show such an association.
Red Meat Consumption May Promote DNA Damage-associated Mutations in Patients with Colorectal Cancer News

Red Meat Consumption May Promote DNA Damage-associated Mutations in Patients with Colorectal Cancer

Genetic mutations indicative of DNA damage were associated with high red meat consumption and increased cancer-related mortality in patients with colorectal cancer, according to a study led by Dana-Farber Cancer Institute researchers and published in Cancer Discovery, a journal of the American Association for Cancer Research.
“45 is the New 50” as Age for Colorectal Cancer Screening is Lowered News

“45 is the New 50” as Age for Colorectal Cancer Screening is Lowered

Prompted by a recent alarming rise in cases of colorectal cancer in people younger than 50, an independent expert panel has recommended that individuals of average risk for the disease begin screening exams at 45 years of age instead of the traditional 50.
New ‘Druggable’ Genetic Targets Identified in Rare Type of Bile Duct Cancer News

New ‘Druggable’ Genetic Targets Identified in Rare Type of Bile Duct Cancer

Scientists are beginning to make inroads into treating cholangiocarcinoma, a rare, lethal cancer of the bile ducts, with precision drugs. Last year, the first targeted drug for some patients with the disease was approved.
Break Through Cancer Launches Collaborative Model Across Top U.S. Research Institutions in Pursuit of Cancer Cures News

Break Through Cancer Launches Collaborative Model Across Top U.S. Research Institutions in Pursuit of Cancer Cures

Break Through Cancer today announced its formal launch as a public foundation designed to find new solutions to the most intractable challenges in cancer.